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Abstract
Fluorescent microspheres were used to measure antibody-induced capping of leukocyte 
membrane proteins that are immun ologically related to band 3, the anion exchanger of the 
erythrocyte. The degree of capping was found to increase with donor age. Surface labeling 
and capping characteristics of cells from healthy, age-matched controls were not different 
from those from patients with Alzheimer’s disease, multi-infarct dementia, and Down’s 
syndrome. Immunoblots, however, indicated increased expression and/or breakdown of band 
3-like proteins in leukocytes from patients when compared with young and old control 
donors. These findings emphasize the possible involvement of band 3-like proteins of 
nucleated cells in aging and disease.
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1. Introduction
During the last few years, it has become clear that band 3, the anion transporter 
of the human erythrocyte, belongs to the gene family of anion exchanger proteins 
[1,2]. The various members of this family presently known (AE1 or band 3, AE2, 
AE3) have been described to be expressed in many different cells and tissues, 
including white blood cells [1,2]. The AE proteins share extensive structural 
homology in their membrane domain and, in agreement with the exclusive involve­
ment of the membrane domain of AE1 in chloride/bicarbonate exchange, they all 
seem to play a role in anion exchange-based regulation of intracellular pH [3,4]. 
The cytoplasmic domains of the AE members show considerable diversity, possibly 
reflecting their tissue-specific interaction with intracellular elements such as the 
cytoskeleton [1 ,2].
In addition to anion transport and providing an anchor site for the cytoskeleton, 
AE1 plays a pivotal role in erythrocyte aging (for a recent review, see [5]). 
Age-dependent changes in AE1 conformation result in the appearance of a neo­
antigen, leading to recognition and removal of old cells by the immune system. The 
mechanism that underlies these age-related changes in AE1, and that may also be 
active in other cell types, seems to be altered in various diseases, including 
Alzheimer’s disease [5-8]. Aging- and disease-related changes in AE1 structure 
affect anion transport as well as interaction of AE1 with the cytoskeleton [5], The 
capping behaviour of surface receptors, i.e. their aggregation within the plasma 
membrane upon binding of an external agent such as an antibody, may indicate, 
among other things, the strength of their association with the cytoskeleton [9].
It occurred to us that aging- and disease-related changes in capping behaviour of 
AE proteins might identify aging- and/or disease-related, structural alterations. 
Therefore, in the course of our studies on the involvement of AE proteins in normal 
and pathological aging [6,7], we investigated the effect of normal aging on capping 
of band 3-like (AE) molecules in white blood ceils. We compared the capping 
characteristics of band 3-like proteins in white blood cells from young and old 
control donors with those of patients with Alzheimer-like dementia (AD), of 
patients with multi-infarct dementia (MID), and of individuals with Down’s 
syndrome (DS). For this purpose we adapted a method to visualize antigens with 
fluorescent microspheres [10] in order to visualize antibody-induced capping.
In this report we describe an age-dependent increase in band 3 capping in 
leukocytes, as well as an apparent increase in breakdown of band 3-like proteins in 
the leukocyte fraction of the patient donor groups.
2. Materials and methods
2.1. Patients
Patients with the diagnosis dementia of the Alzheimer-type (AD, 81 +  5 years, 
n =  8) and multi-infarct dementia (MID, 82 ±  4 years, n =  8) were from a local 
psycho geriatric institution. Young controls (YC, 29 + 5 years, n =  8) were 
laboratory coworkers, and old, healthy controls (OC, 82 +  5 years, n =  8) were
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from two local homes for the elderly. Down’s syndrome patients (DS, non-de- 
mented 26 ±  3 years, n = 3; demented, 60 years, n — 2) were from an institution for 
the mentally handicapped. The diagnostic criteria used for selection of the various 
patient and control groups, as well as their clinical data have been described before 
[6,11-13]. None of the donors had any immunological disorders, or used medica­
tions known to affect the immune system [6],
2.2. Nucleated blood cell isolation
Blood was collected with EDTA as anticoagulant, and nucleated blood cells were 
isolated using a Ficoll-Paque gradient (Pharmacia LKB Biotechnology, Inc., Piscat- 
away, NJ) as described before [6]. The viability of the various preparations was at 
least 95% as indicated by the ability of the cells to exclude trypan blue,
2.3. Anti-band 3 antibodies
Anti-band 3 antibodies (PM1B3) were raised in rabbits against the membrane 
domain of human erythrocyte band 3. Their immunoreactivity pattern with ery­
throcyte band 3 has been described before [13].
¿L
Fig. 1. Labeling and capping of band 3-like proteins in white blood cells, visualized with fluorescent 
microspheres. Cells were incubated with an antiserum against the membrane domain of band 3 as 
described in the Materials and methods section. Shown are examples of three possible results. Panel 1, 
from top to bottom: labeling without capping, completely covered with microspheres, and labeled with 
capping; Panel 2, from top to bottom: capping, labeled without capping, capping.
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2.4. Microsphere capping assay
Lym phocytes (4 x 105 cells) were incubated  with rabb it an ti-h u m an  b an d  3 
antiserum  PM 1B 3, diluted (1:4000) w ith  phosphate-buffered sa line /1% bovine 
serum album in  (PBS/BSA) for 15 min at 37°C. A fter this period, cells were washed 
four times w ith  ice-cold PBS/BSA by centrifugation (100 x g  x  5 m in), an d  fixed 
with form aldehyde (pH  7.0; 0.025% in PBS) for 30 min a t  18°C. L abeling  of 
fluorescent m icrospheres (Covaspheres M X , D u k e  Scientific Co., Palo Alto, CA) 
with swine-anti rabb it  IgG, and  labeling o f  the cells with the coa ted  m icrospheres 
were perfo rm ed  exactly as described before [10]. The final cell pellet was resus­
pended  in 15 //I PBS/BSA, and 100-200 cells were evaluated at 400 x m agnifica­
tion u n d e r  a fluorescence microscope as in [10]. Cells were g rouped  into  four 
categories: lacking any microspheres, completely covered with m icrospheres, n o n ­
capping  (the —  individually visible —  microspheres were evenly d is tr ibu ted  on the 
cell surface), and  capping (the fluorescence was restricted to less th an  one  h a lf  of 
the cell surface [14,15] (Fig. 1). Capping characteristics were determ ined  by one of 
us (B,D*S.), w ho h ad  no previous inform ation  o f  the clinical d a ta  o f  the  donors. 
B lanks consisting o f  preserum resulted in less than  2% labeled cells.
2.5. Immunoblot analysis
H om ogena tes  o f  nucleated b lood  cells were p rep a red  following the p rocedu re  of 
[16], and  analyzed by im m unoblo tting  as described before [7], using the same 
antiserum  th a t  was used for the capping studies (PM1B3, 1:500, [13]). All lanes 
contained  the same am o u n t o f  protein  (10 ¡.ig).
3. Results
3.1. Capping assay conditions
A n tib o d y  dilutions resulting in labeling o f the  highest percentage o f  cells (‘m ax i­
mal labeling5), an d  incubation time and tem perature  resulting in the  h ighest num ber 
o f  labeled cells showing capping (‘m axim al capp ing5), were determ ined  using  white 
b lood  cell p repara tions  from  young control donors. O ptim al an tib o d y  dilutions 
were determ ined  by com binations o f serial dilutions (1:100-1:20 000 final dilution) 
o f  the  rabb it  an ti-band  3 antiserum  PM 1B3 and  swine-anti rab b it  Ig G  (SA R ), and 
the highest d ilu tions still yielding maxim al labeling were used. These dilu tions were 
1:4500 for PM 1B3 and  1:4000 for SAR. T he m ean  m axim al percentage o f  labeled 
cells was 64 ±  11% (range, 50-85% ; n = 7). V aria tion  o f incuba tion  time and 
tem pera tu re  showed tha t capping was tem perature-dependent; the  h ighest percen t­
age o f  capp ing  cells (32 ±  3%; range 26 -37% ; n — 7) was reached  a fte r  15 m in  at
37°C.
3.2. Aging-related capping
T he  n u m b er  o f cells th a t  were n o t  labeled with the an ti-band  3 an tiserum  d id  not 
differ between the various dono r groups (30-40% ; Table 1). T here  also  w as no 
significant difference between the do no r  groups in the fraction  o f  cells th a t  were 
labeled w ith  the antiserum , b u t th a t  displayed no capping, w ith  the  exception o f  the
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Table 1
Labeling and capping of band 3-like molecules in white blood cells of various donor groups1
Donor Unlabeled Labeled without 
capping
Capping
YC (7) 36 +  7 3 3 + 5 32 +  3
OC (8) 35 ± 6 23 + 4** 42 + 5*
MID (8) 36 +  5 24 +  5** 4 0 + 1 *
AD (8) 32 ± 9 26 +4** 42 + 7*
DS (5) 3 ?± 7 3 8 + 4 29 + 7
YC, young controls; OC, old, age-matched controls; M ID, patients with multi-infarct dementia; AD, 
patients with senile dementia of the Alzheimer type; DS, donors with Down’s syndrome.
“ White blood cells were labeled with anti-erythrocyte band 3 antiserum, and the degree of capping 
was determined with fluorescent microspheres as described in the Materials and methods section. Values 
represent percentages of total cells. The number of donors that was measured in one group is given in 
parentheses. The fraction 'Labeled without capping' also contains the cells fully covered with micro- 
spheres (see also the Materials and methods section).
* Significantly different (P <  0.01) from the value of YC.
** Significantly different (P < 0.05) from the value of DS.
DS group (Table 1). In the DS group, the fraction of capping refractory cells was 
significantly higher than those of the Alzheimer and M ID groups (P <  0.05), but 
especially higher than that of the old control group (P <  0.001). There were no 
notable differences between the young (26 years) and old (60 years) DS donors.
The most striking finding of the capping studies is that in the white blood cells 
that were labeled with the anti-band 3 antiserum, capping of band 3-like molecules 
in the plasma membrane increases with donor age. The fraction of cells that showed 
capping was significantly increased in the older donors when compared with the 
young controls (Table 1). There was a significant positive correlation between 
donor age and percentage of cells with capping (r =  0.87; P<0.01), We did not 
observe any Alzheimer-specific changes in capping of band 3-like molecules in white 
blood cells from Alzheimer patients; there were no significant differences between 
the AD patients, the MID patients, and the age-matched (old) control group (Table 
1 ). It is noteworthy that the fraction of capping cells in the DS group was similar 
to that of the young control group, and also significantly smaller than that found 
in the AD, MID, and OC groups (Table 1).
3.3. Immunoblots
The white blood cell proteins from the same donor groups used in the capping 
analysis, were analyzed on immunoblots with the same antiserum against the 
membrane domain of erythrocyte band 3 that was used for the capping studies. In 
addition to the expected reaction of this antiserum with proteins in the 95- to 
110-kDa molecular weight region of intact band 3, all fractions contained im- 
munoreactive proteins of smaller apparent molecular weights (Fig. 2). These smaller
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polypeptides arise either by breakdown of the native proteins, or may represent 
incomplete molecules [1,8]. Initial analysis indicated the presence of an anti-band 3 
immunoreactive polypeptide with an apparent molecular weight of ~  40 kDa in 
Alzheimer patients, but not in young and age-matched control donors. More 
extensive analysis, however, showed the presence of this polypeptide in the cells 
from all donors with pathology, but its almost complete absence in the white blood 
cells of young and old controls (Fig. 2). Also, the fractions of the patient groups 
seem to contain more proteins in the higher molecular weight regions. These 
differences were only observed with antibodies raised against the membrane domain 
of AE1, and not with antibodies specific for AE2 (data not shown).
4. Discussion
Detection of surface molecules on intact cells using fluorescent microspheres has
several advantages compared with classical methods: a high sensitivity, a high
i
signal/noise ratio, and (from a practical viewpoint) resistance against bleaching, and 
no need for dark room conditions for evaluation and quantification. One of us 
already demonstrated the potential of fluorescent microspheres for detection of very 
early erythrocyte chimaerism in patients with bone marrow transplants [10]. Here 
we have successfully applied fluorescent microspheres to the measurement of 
antibody-induced capping in nucleated blood cells.
Polypeptides of the AE family related to band 3 and senescent cell antigen are 
present in white blood cells [17-19]. At present the exact identity of these proteins 
and their distribution over the various cell types is not clear, but our preliminary 
immunochemical and RNA typing indicate that both AE1 and AE2 are expressed 
in white blood cells [19], Capping of band 3-like molecules in white blood cells has 
been described before [17,18], and we show here that the extent of capping increases 
with increasing donor age, This is in sharp contrast with the age-related decrease of 
capping of other membrane receptors in white blood cells [14]. The increase in 
anti-band 3-induced capping seems to be related only to age, and showed no 
pathological component; we observed no differences in capping between the old 
controls and the (old) patient groups. This indicates that the process(es) responsible 
for this increase, through changes either in band 3-like molecules or in cytoskeleton 
proteins, is (are) not visibly affected in Alzheimer’s disease. Changes in actin 
molecules of white blood cells, that play an important role in receptor capping [9], 
or in other components of the cytoskeleton in neurons, have been reported for 
Alzheimer patients [8,20]. It cannot be excluded that various Alzheimer-related 
changes have counteractive effects on the capping behaviour of AE proteins, 
resulting in overall identical capping behaviour in aged controls and AD patients, 
but at present we must conclude that capping of band 3-like molecules in the 
plasma membrane of white blood cells is not affected by Alzheimer's disease.
One explanation for increased mobility of band 3-like molecules within the 
membrane may be proteolytic breakdown, resulting in a decreased interaction with 
the cytoskeleton. Age- and disease-related breakdown of band 3 probably plays a 
pivotal role in the mechanism that leads to recognition and removal of old
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Fig. 2. Immunobiot analysis of band 3-likc molecules in white blood cells of various donor groups. Cell 
homogenates were prepared and analyzed by immunoblotting using an antiserum raised against 
erythrocyte band 3 as described in the Materials and methods section. All lanes contained 10 /¿g of 
protein, and the various blots were incubated and developed under identical conditions. For proper 
comparison, care was taken that the original blots contained the maximum number possible (3- 4) of 
samples from the various donor groups (each group consisted of eight donors). YC, young controls; OC, 
old, age-matched controls; MID, patients with multi-infarct dementia; AD, patients with Alzheimer’s 
disease; DS, patients with Down’s syndrome,
erythrocytes by the immune system [5]. Immunobiot analysis, however, does not 
show any evidence for increased band 3 breakdown in lymphocytes from old 
control donors. Also, increased breakdown of band 3-like molecules, as especially 
apparent from the presence of a new immunoreactive band of 40 kDa, occurs in all 
the patient groups, including the DS group that has norma] ‘young5 capping 
characteristics. Thus, it is unlikely that the age-related increase in capping of band
3-like molecules is directly related to increased synthesis or breakdown. However, 
one could speculate that the aging-related changes in capping of band 3-like 
membrane proteins may be related to aging-related shifts in cell populations with 
different capping characteristics, such as a changed composition o f the T cell 
compartment [21]. Such aging- and/or disease- related shifts may also be responsi­
ble for the differences in band 3-like proteins in the 95- to 110-kDa region between 
the various donor groups (Fig. 2), Thorough investigation of the age-related 
changes in capping, in relation to those occurring between and within leukocyte 
populations, however, requires analysis of the capping properties and AE expres­
sion in individual lymphocyte populations of a large number of donors of various 
ages. Such studies have been initiated.
If the 40-kDa, band 3-related, protein is specific for a certain cell type, the 
apparently disease-related presence of the 40-kDa immunoreactive protein could be 
a reflection of a derangement of the major white blood cell subsets reported in DS 
patients [22], or of the changes in T cells in AD and MID patients [23], Alterna­
tively, structural changes in band 3-like proteins could be related to perturbation of 
intracellular ion fluxes, e.g. in the secondary messenger compartment, considering 
the decrease in intracellular calcium response of CD4 +  cells in Alzheimer’s disease 
and Down's syndrome patients recently described [24], These possibilities are 
currently under investigation.
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Age- and Alzheimer-related changes in structure and function o f AE proteins 
have recently been described in erythrocytes, as well as in neurons [6,7]. The data 
we present here provide further support for the hypothesis that molecular charac­
terization of the aging-related changes in band 3-like (AE) proteins may illuminate 
the mechanism(s) and consequences of normal cellular aging and degeneration 
[8,25]. This may be of broader relevance in view of the putative function o f band 
3-like proteins in immune cells [26,27], and o f the changes in immunological 
parameters, which occur during normal aging and in patients with Alzheimer's
disease [21,23,28,29],
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